HK Stock Market Move | MICROPORT (00853) is now falling by more than 5%, expecting a loss of up to 110 million US dollars in the first half of the year. The restructuring of the CRM business may be aimed at reducing risks related to the redemption of bets.

MICROPORT (00853) is currently down more than 5%, with a decrease of 5.1% as of press time, trading at 8.75 Hong Kong dollars with a trading volume of 1.57 billion Hong Kong dollars. In terms of news, MICROPORT announced that it expects the group's revenue in the first half of the year to decline by no more than 4% year-on-year (excluding the impact of exchange rates). Apart from the Siasun Robot & Automation business, other main business segments have experienced varying degrees of decline or slowed growth in revenue. The interim loss is expected to not exceed 110 million US dollars, compared to a loss of approximately 107 million US dollars in the same period last year. It is worth noting that MICROPORT announced plans to merge its cardiac rhythm management business with its subsidiary Mindray Medical. It is reported that in July 2021, MICROPORT introduced institutional investors such as Hillhouse Capital for its minimally invasive cardiac rhythm business, but it was agreed that if the minimally invasive cardiac rhythm business did not go public by July 17, 2025, and its post-listing market value did not reach 1.5 billion US dollars or raise less than 150 million US dollars, Hillhouse Capital and other institutional investors have the right to require the redemption of shares in the minimally invasive cardiac rhythm business. Analysts point out that MICROPORT is currently attempting to reduce the risk of the redemption of the bet by using the shell of its former bet.